Developing a biocompatible contrast agent with high stability and favorable magnetism for sensitive detection of malignant tumors using magnetic resonance imaging (MRI) remains a great demand in clinical. Nowadays, the fine control of magnetic iron oxide nanoparticle (MION) sizes from a few nanometers to dozens of nanometers can be realized through a thermal decomposition method of iron precursors. This progress allows us to research accurately on the size dependence of magnetic properties of MION, involving saturation magnetization (M s ), specific absorption rate (SAR), and relaxivity. Here, we synthesized MION in a size range between 14 and 26 nm and modified them with DSPE-PEG2000 for biomedical use. The magnetic properties of PEGylated MION increased monotonically with MION size, while the nonspecific uptake of MION also enhanced with size through cell experiments. The MION with the size of 22 nm as a T2-weighted contrast agent presented the best contrastenhancing effect comparing with other sizes in vivo MRI of murine tumor. Therefore, the MION of 22 nm may have potential to serve as an ideal MRI contrast agent for tumor detection.
Introduction
Over the past few decades, numerous researches have focused on nanomaterials for biomedical applications, among which magnetic iron oxide nanoparticles (MIONs) have become the most promising candidate owing to their excellent biocompatibility and outstanding magnetic properties. The magnetic nanoparticles have been widely applied to in vivo use, such as magnetic resonance imaging (MRI) [1] [2] [3] , magnetic-induced hyperthermia [4, 5] , switching cellular activity [6] [7] [8] , or magnetically guided drug/gene delivery [9] [10] [11] . Among them, MRI is one of the key applications in which magnetic nanoparticles are used as contrast-enhancing agents for improving the sensitivity of MRI. Moreover, several iron oxide nanoparticles including Feridex and Resovist have been approved as contrast agents for T 2 -weighted MR imaging in clinical for years. Nevertheless, due to their synthetic method of coprecipitation, the products are polydisperse with low crystallinity, which results in relatively inferior magnetic properties. Benefit from the introduction of a thermal decomposition method, uniform iron oxide nanoparticles with high crystallinity and controlled sizes can be synthesized through adjusting the molar ratios of surfactants used in the reaction [12] , which made it possible to do a precise study on properties of iron oxide nanoparticles with different sizes.
Previous reports showed that magnetic properties of iron oxide nanoparticles such as saturation magnetization (M s ), specific absorption rate (SAR), and relaxivity (r 2 ) have a close relationship with their sizes among a large size range from a few nanometers to hundreds of nanometers [2, [13] [14] [15] [16] [17] . Tong et al. [16] reported that the M s of MION increased slightly with size from 6 to 40 nm, and the SAR values increased monotonically with size enlarged (325 kHz, 20.7 kA/m), while SAR was really low for MION below 11 nm. In another study, the SAR values of Fe 3 O 4 nanoparticles synthesized by coprecipitation with diameters from 7.5 to 416 nm were measured under an external alternating magnetic field (80 kHz, 32.5 kA/m), and the nanoparticles of 46 nm exhibited the highest SAR [13] . Lartigue et al. [15] prepared sugar-coated iron oxide nanoparticles, and the SAR values (168 kHz, 21 kA/m) gradually increased from 4 to 35 nm, meanwhile the r 2 values also enlarged from 4 to 18 nm, while the nanoparticles of 35 nm were excluded from use in MRI because of the precipitation problems which may cause risks of thrombosis in clinical. On the basis of these results, it was concluded that the magnetic properties (M s , SAR, and r 2 ) were relatively low for small sizes of the MION below 14 nm. In addition, the interaction between particles enhanced with their size increased, which will result in aggregation and instability in solution.
Owing to these reasons, this study will focus on MION with size from 14 to 26 nm for suitable in vivo applications used as MRI contrast agents.
It is noteworthy that understanding and controlling of their properties is extremely important for effective in vivo application of MION. In addition, as MRI contrastenhancing agents, it is essential for MION to possess good magnetic behavior as well as biocompatible surface. As the products of thermal decomposition need further surface modification to be water-soluble, amphiphilic molecular DSPE-PEG is one of the common choices which can make the MION singly encapsulated in water solution [18] . The PEGylation of MION with DSPE-PEG cannot only provide a stable layer to prevent agglomeration but also dramatically reduce nonspecific uptake by macrophages and improve blood circulation time when in a physiological environment. According to the previous report, the endocytosis of nanoparticles was sizedependent [19] , so it is necessary to evaluate the antiphagocytosis ability of the MION with different sizes for in vivo uses.
In this work, we report a precise study on size-dependent properties of MION synthesized by a thermal decomposition method capable of yielding nanoparticles in a size range between 14 and 26 nm as a T 2 -weighted contrast agent for MRI. Herein, the synthesized MIONs were first decorated with DSPE-PEG2000 before performance measurements. Our study demonstrated that the properties of MION such as M s , SAR, and r 2 relaxivity were all dependent on size and enhanced monotonically with MION size from 14 to 26 nm. In vitro cell experiments indicated that the nonspecific uptake of MION by macrophages was also in a sizedependent way. The in vivo MRI of murine tumor elucidated the availability of MION as T 2 -weighted contrast-enhancing agents, especially for the MION of 22 nm which was proven to present the best imaging effect. As a result, the size of 22 nm may be the most appropriate selection used for in vivo MRI. 3 according to literature [12, 20] . The size-controlled MIONs were produced by adjusting the molar ratios of OA to OAm. In synthesis of MION of 14, 18, 22, and 26 nm, a 100 ml three-neck flask was prepared with 2 mmol Fe(acac) 3 and 20 ml benzyl ether inside, 9 mmol OA and 3 mmol OAm, 8 mmol OA and 4 mmol OAm, 7.5 mmol OA and 4.5 mmol OAm, or 6 mmol OA and 6 mmol OAm were added, respectively. Under the protection of N 2 with an appropriate flow, the mixture was first heated to 220°C in 1 h at a heating rate of 3.3°C/min and kept at 220°C for 1 h, then heated to 290°C in 30 min and maintained this temperature for 30 min. After reaction finished, the product was transferred to a beaker of 250 ml and washed 3 times by ethanol on the magnet. Lastly, the synthetic Fe 3 O 4 @OA were dispersed in chloroform in a conical flask and stored in room temperature.
Experimental

PEGylation of Iron Oxide Nanoparticles with Different
Sizes. As the oleic acid-(OA-) coated MIONs were hydrophobic, they need further modification with biocompatible material to be bioavailable. Herein, DSPE-PEG2000 which was approved by FDA for clinical application was used to decorate Fe 3 O 4 @OA according to our previous work with some modifications [20] [21] [22] . For PEGylation of MION with different sizes of 14, 18, 22, and 26 nm, DSPE-PEG2000 dissolved in 3 ml chloroform at the concentration of 17, 13, 10, or 8 mg/ml was, respectively, placed in a 25 ml roundbottom flask, mixing with 10 mg (Fe content) Fe 3 O 4 @OA dissolved in 3 ml chloroform by ultrasonic dissolving. Six milliliters deionized water was then added and mixed with the reactant. The reaction was proceeded (70°C for 10 min) using a rotary evaporator to remove the chloroform completely. Magnetic separation method was then applied to purify the resultant water-soluble MION (Fe 3 O 4 @PEG) by eliminating the empty lipid micelles simultaneously formed during the course of PEGylation. After purification, Fe 3 O 4 @PEG of different sizes were stored at 4°C. HUVECs and 4T1 cells were cultured in PRMI-1640 medium supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C and 5% CO 2 in a humidified incubator. RAW264.7 macrophages were cultured in DMEM medium supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C and 5% CO 2 in a humidified incubator.
Characterization of
The 4T1 breast cancer cells and HUVECs were used for assessing the cytotoxicity of PEGylated MION of four sizes. These two cell lines were, respectively, seeded in 96-well plates with 10 4 cells per well (n = 4) and grew overnight. Subsequently, Fe 3 O 4 @PEG (14, 18, 22, and 26 nm) were added, respectively, with the final concentration of 0-100 μg ml −1 . After 24 h cocultivation at 37°C, CCK8 assay was used to measure the cell viability.
The nonspecific phagocytosis of Fe 3 O 4 @PEG of four sizes was investigated by RAW264.7 macrophages which were incubated in several 12-well plates. After adherence, the cells were, respectively, incubated with PEGylated MION of four different sizes and MDSA-modified MION (Fe 3 O 4 @DMSA, 10 nm) at a concentration of 100 μg ml −1 at 37°C. Fe 3 O 4 @DMSA (2,3-dimercaptosuccinic acid) was synthesized according to the previous work [23] . After coculture of 4 h or 8 h, the culture solution was removed and the cells were washed with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde. Then the iron phagocytized by macrophages was detected by Prussian blue staining. 
Statistical Analysis.
The data were expressed as mean ± SE. Statistical differences were conducted using Student's t-test. The situation of P < 0 05 was considered to have significant difference. The symbol of * represented P < 0 05 and * * represented P < 0 01. Figure S1 showed that the MIONs of 14, 18, and 22 nm were uniform while the size of 26 nm was not so homogeneous. During the preparation of MION, it was found that the synthesis of uniform nanoparticles becomes difficult when the size is larger than 22 nm using this method. As the products of the thermal decomposition method were hydrophobic, biocompatible DSPE-PEG2000 was used for surface modification. As shown in Figure 1 , all the nanoparticles of four different sizes were successfully modified without apparent agglomeration, where a thin layer of DSPE-PEG2000 was visible. The DLS data showed that the hydrodynamic diameters of the as-synthesized MION with different TEM sizes (14, 18, 22 , and 26 nm) were 24, 28, 33, and 38 nm, respectively (Figure 2(a) ). What is more, Fe 3 O 4 @PEG of the four sizes all exhibited excellent stability in aqueous Journal of Nanomaterials solution during a long period of time about 5 months (Figure 2(b) ). In addition to colloidal stability, the magnetic property of MION is another crucial factor for in vivo biomedical applications. The saturation magnetization (M s ) of Fe 3 O 4 @PEG increased with size, and the hysteresis loop exhibited superparamagnetic behavior (Figure 2(c) ). The M s of the four sizes (14, 18, 22 , and 26 nm) was 78, 88, 92, and 97 emu g −1 Fe at room temperature (300 K), respectively. It was worth mentioning that the M s tended to have impact on magnetic heating and MRI contrast effect of MION [25] [26] [27] . In order to assess the magnetically induced heating efficiency under ACMF, SAR value was used as an evaluation criterion. As expected, the measured SAR values (167, 306, 425, and 625 W g −1 Fe) increased monotonically with MION size (14, 18, 22, and 26 nm) (Figure 2(d) ), which was accord with the previous literature [16] . The high SAR value indicated that the MIONs have potential as magnetic fluid hyperthermia agents for magnetic hyperthermia of tumors, which makes it possible to realize diagnosis and treatment simultaneously. Moreover, the contrast enhancement capability of MION was measured in vitro. As shown in Figure 2(f) , the MR signal intensity was attenuated as the concentration and size of MION increased. Their corresponding relaxivity coefficient (r 2 ) values were, respectively, calculated as 262, 398, 549, and 615 mM −1 s −1 (Figure 2(e) ), which was much larger than Feridex (133 mM
Results and Discussion
) in the previous report [28] . The high r 2 values ensured the effectiveness RAW 264.7 macrophage phagocytosis experiments were conducted to assess the capability of Fe 3 O 4 @PEG with four different sizes to escape the nonspecific uptake by a reticuloendothelial system (RES). As it was easy to be phagocytosed by macrophages, DMSA-modified MION was generally used for positive comparison [29, 30] . After incubation with * -weighted MR images of tumor region were recorded before and 3 h postinjection of the contrast agent at a dosage of 10 mg Fe per kilogram body weight. As shown in Figure 4(a) , there was distinct decrease of the signal intensity in the tumor area of mice, respectively, treated with Fe 3 O 4 @PEG of four sizes. To quantitatively assess the contrast imaging effect resulted from Fe 3 O 4 @PEG, the enhancement degree of tumor tissue on MR images was analyzed as TNR (tumor/normal tissue signal ratio) values between the tumor and the adjacent normal muscle [20] . It means that small TNR values represented favorable imaging effect. After quantitative analysis, it was observed that although Fe 3 O 4 @PEG of all the four sizes had imaging function, the contrast enhancement effect was different. It has been shown in Figure 4 (b) that the MION of 22 nm displayed the best contrast effect followed by that of 14 nm, while the MION of 26 nm exhibited the worst.
In combination with the previous results involving characterization and phagocytosis test, as the enlargement of MION size, the magnetic property improved while the capacity of antiphagocytosis decreased. Collectively, there should be optimal mediation between the performance and antiphagocytosis of MION for in vivo MR imaging as a contrast agent. The enhanced MRI contrast of the MION of 22 nm in the tumor may be a combined result of the size-dependent property and captured by macrophages. Therefore, the size of 22 nm might be more suitable for imaging, as well as holds a great potential for tumor hyperthermia in consideration of the relatively high heating efficiency under ACMF. low dosage of injection, there was a small quantity of blue spots observed in the abovementioned tissues. Furthermore, H&E staining displayed no obvious damage of main organs ( Figure S2 ), which further verified the safety of Fe 3 O 4 @PEG as a contrast agent applied in the living body.
Conclusion
In conclusion, we have synthesized MION with four different sizes by a thermal decomposition method and presented a precise study on size-dependent properties of the MION for further in vivo MR imaging. Through measurement of magnetic properties, these MION exhibited favorable performance depending on size. In vitro cell experiments confirmed the biocompatibility of these MIONs and the capacity of antiphagocytosis except the MION with the size of 26 nm. After in vivo imaging, the MION of 22 nm was identified to be the optimal size applied as a contrast agent for T 2 * -weighted MR imaging. We also concluded that, for size selection of magnetic nanoparticles in in vivo applications, it is important to consider the balance between the magnetic properties and antiphagocytosis capability.
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